{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:09Z","timestamp":1791389169664,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071443"],"award-info":[{"award-number":["82071443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.msard.2022.104071","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T12:47:51Z","timestamp":1658753271000},"page":"104071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency"],"prefix":"10.1016","volume":"66","author":[{"given":"Meng-Ting","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4462-171X","authenticated-orcid":false,"given":"Yin-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ping","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2022.104071_bib0001","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.msard.2022.104071_bib0002","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1212\/WNL.0000000000006990","article-title":"Autoimmune encephalitis: a costly condition","volume":"92","author":"Cohen","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2022.104071_bib0003","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the therapeutics and technology assessment subcommittee of the american academy of neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2022.104071_bib0004","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOH.0000000000000535","article-title":"Transfusion support and alternatives for Jehovah's Witness patients","volume":"26","author":"Crowe","year":"2019","journal-title":"Curr. Opin. Hematol."},{"issue":"3","key":"10.1016\/j.msard.2022.104071_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2019.04.007","article-title":"Therapeutic plasma exchange: review of current indications","volume":"58","author":"Fernandez-Zarzoso","year":"2019","journal-title":"Transfus Apher Sci."},{"issue":"2","key":"10.1016\/j.msard.2022.104071_bib0006","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1212\/NXI.0000000000000958","article-title":"Long-term functional outcomes and relapse of anti-NMDA receptor encephalitis: a cohort study in western China","volume":"8","author":"Gong","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.msard.2022.104071_bib0007","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.35.4.538","article-title":"Neuronal antinuclear antibody in sensory neuronopathy from lung cancer","volume":"35","author":"Graus","year":"1985","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2022.104071_bib0008","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2022.104071_bib0009","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.msard.2022.104071_bib0010","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00415-016-8277-y","article-title":"Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study","volume":"263","author":"Heine","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.104071_bib0011","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fimmu.2019.00324","article-title":"Application of plasma exchange in steroid-responsive encephalopathy","volume":"10","author":"Jiang","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2022.104071_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J. Clin. Neurol."},{"issue":"9451","key":"10.1016\/j.msard.2022.104071_bib0013","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.msard.2022.104071_bib0014","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1212\/NXI.0000000000000891","article-title":"Direct economic burden of patients with autoimmune encephalitis in western China","volume":"7","author":"Li","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2022.104071_bib0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2022.104071_bib0016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","article-title":"Intravenous immunoglobulin in neurology-mode of action and clinical efficacy","volume":"11","author":"Lunemann","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.104071_bib0017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s13311-015-0391-5","article-title":"Efficacy of intravenous immunoglobulin in neurological diseases","volume":"13","author":"Lunemann","year":"2016","journal-title":"Neurotherapeutics"},{"issue":"13","key":"10.1016\/j.msard.2022.104071_bib0018","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1352458520905485","article-title":"Autoimmune encephalitis management: MS centers and beyond","volume":"26","author":"McKeon","year":"2020","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2022.104071_bib0019","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/practneurol-2019-002336","article-title":"Plasma exchange in neurological disease","volume":"20","author":"Osman","year":"2020","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.msard.2022.104071_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.642078","article-title":"Characteristics and prognosis of autoimmune encephalitis in the east of China: a multi-center study","volume":"12","author":"Qiao","year":"2021","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.104071_bib0021","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00415-019-09590-9","article-title":"The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis","volume":"268","author":"Ramanathan","year":"2021","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.104071_bib0022","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13168","article-title":"Cost-effectiveness of routine screening for autoimmune encephalitis in patients with first-episode psychosis in the United States","volume":"82","author":"Ross","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.msard.2022.104071_bib0023","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/ajh.24889","article-title":"Treatment of individuals who cannot receive blood products for religious or other reasons","volume":"92","author":"Scharman","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.msard.2022.104071_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621599","article-title":"Neuronal surface antibody-medicated autoimmune encephalitis (Limbic Encephalitis) in China: a multiple-center, retrospective study","volume":"12","author":"Shan","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2022.104071_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2022.104071_bib0026","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2022.104071_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/1744-9987.12806","article-title":"Proceedings of the inaugural strategy meeting for the establishment of a Southeast Asia regional therapeutic plasma exchange consortium for neurological disorders","volume":"23","author":"Viswanathan","year":"2019","journal-title":"Ther. Apher. Dial."},{"issue":"1","key":"10.1016\/j.msard.2022.104071_bib0028","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1212\/NXI.0000000000000633","article-title":"Anti-NMDAR encephalitis: a single-center, longitudinal study in China","volume":"7","author":"Xu","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2022.104071_bib0029","series-title":"Corticosteroid Adverse Effects","author":"Yasir","year":"2021"},{"issue":"4","key":"10.1016\/j.msard.2022.104071_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/acn3.51313","article-title":"Clinical efficacy of plasma exchange in patients with autoimmune encephalitis","volume":"8","author":"Zhang","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2022.104071_bib0031","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10072-019-03930-3","article-title":"Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations","volume":"40","author":"Zuliani","year":"2019","journal-title":"Neurol. Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482200579X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482200579X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:04:19Z","timestamp":1761901459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482200579X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"alternative-id":["S221103482200579X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104071","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104071"}}